JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB218311

Anti-p21 antibody [EPR362] - BSA and Azide free

Be the first to review this product! Submit a review

|

(34 Publications)

Anti-p21 antibody [EPR362] - BSA and Azide free (ab218311) is a rabbit recombinant monoclonal antibody provided in a PBS only buffer for easy conjugation detecting p21 in Western Blot, Flow Cytometry (Intra), IP, IHC-P, ICC/IF. Suitable for Human.

- KO validated for confirmed specificity
- BSA, sodium azide, and glycerol-free for easy conjugation
- Biophysical QC for unrivalled batch-batch consistency
- Over 20 publications

View Alternative Names

CAP20, CDKN1, CIP1, MDA6, PIC1, SDI1, WAF1, CDKN1A, Cyclin-dependent kinase inhibitor 1, CDK-interacting protein 1, Melanoma differentiation-associated protein 6, p21, MDA-6

10 Images
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-p21 antibody [EPR362] - BSA and Azide free (AB218311)
  • IHC-P

Unknown

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-p21 antibody [EPR362] - BSA and Azide free (AB218311)

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) analysis of human papillary carcinoma of the thyroid gland tissue labelling p21 with unpurified ab109520 at a dilution of 1/100.

This data was developed using the same antibody clone in a different buffer formulation containing PBS, BSA, glycerol, and sodium azide (ab109520).

Perform heat mediated antigen retrieval before commencing with IHC staining protocol.

Immunocytochemistry/ Immunofluorescence - Anti-p21 antibody [EPR362] - BSA and Azide free (AB218311)
  • ICC/IF

Lab

Immunocytochemistry/ Immunofluorescence - Anti-p21 antibody [EPR362] - BSA and Azide free (AB218311)

Cell line MCF7 (Human breast adenocarcinoma cell line), Target AbID ab109520 anti-p21 ab150077 Alexa Fluor® 488 Goat anti-Rabbit secondary. Counterstain AbID ab195889 Anti-alpha Tubulin antibody [DM1A] - Microtubule Marker (Alexa Fluor® 594). Fixative 4% Paraformaldehyde, Permeabilisation 0.1% tritonX-100, Nuclear counter stain DAPI. Comments Confocal image showing nuclear staining on MCF7 cell line. Target 1oAb dilution 1 : 500 2 μg/ml, Target 2ndry Ab dilution 1 : 1000 2 μg/ml, Counterstain Ab dilution 1 : 200 2.5 μg/ml.

This data was developed using the same antibody clone in a different buffer formulation containing PBS, BSA, glycerol, and sodium azide (ab109520).

Immunocytochemistry/ Immunofluorescence - Anti-p21 antibody [EPR362] - BSA and Azide free (AB218311)
  • ICC/IF

Lab

Immunocytochemistry/ Immunofluorescence - Anti-p21 antibody [EPR362] - BSA and Azide free (AB218311)

Immunocytochemistry/Immunofluorescence analysis of MCF7 cells labelling p21 with purified ab109520 at 1/1000. Cells were fixed with 4% paraformaldehyde and permeabilized with 0.1% Triton X-100. ab150077, an Alexa Fluor® 488-conjugated goat anti-rabbit IgG (1/500) was used as the secondary antibody. DAPI (blue) was used as the nuclear counterstain. ab7291, a mouse anti-tubulin (1/1000) and ab150120, an Alexa Fluor® 594-conjugated goat anti-mouse IgG (1/500) were also used.

Control 1 : primary antibody (1/1000) and secondary antibody, ab150120, an Alexa Fluor® 594-conjugated goat anti-mouse IgG (1/500).

Control 2 : ab7291 (1/1000) and secondary antibody, ab150077, an Alexa Fluor® 488-conjugated goat anti-rabbit IgG (1/500).

This data was developed using the same antibody clone in a different buffer formulation containing PBS, BSA, glycerol, and sodium azide (ab109520).

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-p21 antibody [EPR362] - BSA and Azide free (AB218311)
  • IHC-P

Lab

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-p21 antibody [EPR362] - BSA and Azide free (AB218311)

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) analysis of human thyroid carcinoma tissue labelling p21 with purified ab109520 at 1/100. Heat mediated antigen retrieval was performed using Tris/EDTA buffer pH 9. ab97051, a HRP-conjugated goat anti-rabbit IgG (H+L) was used as the secondary antibody (1/500). Negative control using PBS instead of primary antibody. Counterstained with hematoxylin.

This data was developed using the same antibody clone in a different buffer formulation containing PBS, BSA, glycerol, and sodium azide (ab109520).

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-p21 antibody [EPR362] - BSA and Azide free (AB218311)
  • IHC-P

Unknown

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-p21 antibody [EPR362] - BSA and Azide free (AB218311)

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) analysis of human cervical carcinoma tissue labelling p21 with unpurified ab109520 at a dilution of 1/100.

This data was developed using the same antibody clone in a different buffer formulation containing PBS, BSA, glycerol, and sodium azide (ab109520).

Perform heat mediated antigen retrieval before commencing with IHC staining protocol.

Flow Cytometry (Intracellular) - Anti-p21 antibody [EPR362] - BSA and Azide free (AB218311)
  • Flow Cyt (Intra)

Lab

Flow Cytometry (Intracellular) - Anti-p21 antibody [EPR362] - BSA and Azide free (AB218311)

Overlay histogram showing HeLa cells stained with unpurified ab109520 (red line). The cells were fixed with 80% methanol (5 min) then permeabilized with 0.1% PBS-Tween 20 for 20 min. The cells were then incubated in 1x PBS / 10% normal goat serum / 0.3M glycine to block non-specific protein-protein interactions followed by the antibody (unpurified ab109520, 1/100) for 30 min at 22°C. The secondary antibody used was Alexa Fluor® 488 goat anti-rabbit IgG (H&L) (ab150081) at 1/2000 dilution for 30 min at 22°C. Isotype control antibody (black line) was rabbit IgG (monoclonal) (ab172730, 1μg/1x106 cells) used under the same conditions. Unlabelled sample (blue line) was also used as a control.

Acquisition of >5,000 events were collected using a 20mW Argon ion laser (488nm) and 525/30 bandpass filter.

This data was developed using the same antibody clone in a different buffer formulation containing PBS, BSA, glycerol, and sodium azide (ab109520).

Immunoprecipitation - Anti-p21 antibody [EPR362] - BSA and Azide free (AB218311)
  • IP

Lab

Immunoprecipitation - Anti-p21 antibody [EPR362] - BSA and Azide free (AB218311)

ab109520 (purified) at 1/50 immunoprecipitating p21 in HEK293 whole cell lysate.

Lane 1 (input) : HEK293 whole cell lysate (10μg)

Lane 2 (+) : ab109520 + HEK293 whole cell lysate (10μg).

Lane 3 (-) : Rabbit monoclonal IgG (ab172730) instead of ab109520 in HEK293 whole cell lysate.

For western blotting, ab131366 VeriBlot for IP (HRP) was used for detection at 1/1500 dilution.

Blocking buffer and concentration : 5% NFDM/TBST.

Diluting buffer and concentration : 5% NFDM /TBST.

This data was developed using the same antibody clone in a different buffer formulation containing PBS, BSA, glycerol, and sodium azide (ab109520).

All lanes:

Immunoprecipitation - Anti-p21 antibody [EPR362] (<a href='/en-us/products/primary-antibodies/p21-antibody-epr362-ab109520'>ab109520</a>)

Predicted band size: 18 kDa

Observed band size: 21 kDa

false

Western blot - Anti-p21 antibody [EPR362] - BSA and Azide free (AB218311)
  • WB

Lab

Western blot - Anti-p21 antibody [EPR362] - BSA and Azide free (AB218311)

False colour image of Western blot : Anti-p21 antibody [EPR362] staining at 1/1000 dilution, shown in green; Mouse anti-Alpha Tubulin [DM1A] (ab7291) loading control staining at 1/20000 dilution, shown in red. In Western blot, ab109520 was shown to bind specifically to p21. A band was observed at 21 kDa in wild-type HeLa cell lysates with no signal observed at this size in CDKN1A knockout cell line ab255349 (knockout cell lysate ab263812). To generate this image, wild-type and CDKN1A knockout y cell lysates were analysed. First, samples were run on an SDS-PAGE gel then transferred onto a nitrocellulose membrane. Membranes were blocked in 3 % milk in TBS-0.1 % Tween® 20 (TBS-T) before incubation with primary antibodies overnight at 4 °C. Blots were washed four times in TBS-T, incubated with secondary antibodies for 1 h at room temperature, washed again four times then imaged.Secondary antibodies used were Goat anti-Rabbit IgG H&L (IRDye® 800CW) preabsorbed (ab216773) and Goat anti-Mouse IgG H&L (IRDye® 680RD) preabsorbed (ab216776) at 1/20000 dilution.

This data was developed using the same antibody clone in a different buffer formulation containing PBS, BSA, glycerol, and sodium azide (ab109520).

All lanes:

Western blot - Anti-p21 antibody [EPR362] (<a href='/en-us/products/primary-antibodies/p21-antibody-epr362-ab109520'>ab109520</a>) at 1/1000 dilution

Lane 1:

wild-type HeLa Vehicle Control Fluvastatin (20 uM, 24 h) cell lysate at 20 µg

Lane 2:

wild-type HeLa Treated Fluvastatin (50 uM, 24 h) cell lysate at 20 µg

Lane 3:

CDKN1A knockout HeLa Vehicle Control Fluvastatin (20 uM, 24 h) cell lysate at 20 µg

Lanes 3 - 4:

Western blot - Human CDKN1A knockout HeLa cell line (<a href='/en-us/products/cell-lines/human-cdkn1a-knockout-hela-cell-line-ab255349'>ab255349</a>)

Lane 4:

CDKN1A knockout HeLa Treated Fluvastatin (50 uM, 24 h) cell lysate at 20 µg

Lane 5:

MCF7 cell lysate at 20 µg

Lane 6:

SH-SY5Y cell lysate at 20 µg

Predicted band size: 18 kDa

Observed band size: 21 kDa

false

Western blot - Anti-p21 antibody [EPR362] - BSA and Azide free (AB218311)
  • WB

Lab

Western blot - Anti-p21 antibody [EPR362] - BSA and Azide free (AB218311)

This data was developed using ab109520, the same antibody clone in a different buffer formulation. Different batches of ab109520 were tested on MCF7 (Human breast adenocarcinoma epithelial cell) lysate at 0.2 µg/ml. 15 µg of lysate was loaded in each lane. Bands observed at 21 kDa.

All lanes:

Western blot - Anti-p21 antibody [EPR362] (<a href='/en-us/products/primary-antibodies/p21-antibody-epr362-ab109520'>ab109520</a>)

Predicted band size: 18 kDa

false

Western blot - Anti-p21 antibody [EPR362] - BSA and Azide free (AB218311)
  • WB

Lab

Western blot - Anti-p21 antibody [EPR362] - BSA and Azide free (AB218311)

This data was developed using the same antibody clone in a different buffer formulation containing PBS, BSA, glycerol, and sodium azide (ab109520). Western blot : Anti-CDKN1A antibody [EPR362] (ab109520) staining at 1/1000 dilution, shown in green; Mouse anti-GAPDH antibody [6C5] (ab8245) loading control staining at 1/20000 dilution, shown in red. In Western blot, ab109520 was shown to bind specifically to CDKN1A. A band was observed at 21 kDa in wild-type HCT 116 cell lysates with no signal observed at this size in CDKN1A knockout cell line. To generate this image, wild-type and CDKN1A knockout HCT 116 cell lysates were analysed. First, samples were run on an SDS-PAGE gel then transferred onto a nitrocellulose membrane. Membranes were blocked in 3 % milk in TBS-0.1 % Tween® 20 (TBS-T) before incubation with primary antibodies overnight at 4 °C. Blots were washed four times in TBS-T, incubated with secondary antibodies for 1 h at room temperature, washed again four times then imaged. Secondary antibodies used were Goat anti-Rabbit IgG H&L 800CW and Goat anti-Mouse IgG H&L 680RD at 1/20000 dilution.

All lanes:

Western blot - Anti-p21 antibody [EPR362] (<a href='/en-us/products/primary-antibodies/p21-antibody-epr362-ab109520'>ab109520</a>) at 1/1000 dilution

Lane 1:

Wild-type HCT 116 cell lysate at 20 µg

Lane 2:

Western blot - Human CDKN1A knockout HCT116 cell line (<a href='/en-us/products/cell-lines/human-cdkn1a-knockout-hct116-cell-line-ab288187'>ab288187</a>)

Lane 2:

CDKN1A knockout HCT 116 cell lysate at 20 µg

Lane 3:

Wild-type MCF7 cell lysate at 20 µg

Lane 4:

Western blot - Human CDKN1A knockout MCF7 cell line (<a href='/en-us/products/cell-lines/human-cdkn1a-knockout-mcf7-cell-line-ab288200'>ab288200</a>)

Lane 4:

CDKN1A knockout MCF7 cell lysate at 20 µg

Lane 5:

Wild-type A549 cell lysate at 20 µg

Lane 6:

Western blot - Human CDKN1A knockout A549 cell line (<a href='/en-us/products/cell-lines/human-cdkn1a-knockout-a549-cell-line-ab288213'>ab288213</a>)

Lane 6:

CDKN1A knockout A549 cell lysate at 20 µg

Secondary

All lanes:

Goat anti-Rabbit IgG H&L 800CW and Goat anti-Mouse IgG H&L 680RD at 1/20000 dilution

Predicted band size: 21 kDa

Observed band size: 21 kDa

false

Key facts

Host species

Rabbit

Clonality

Monoclonal

Clone number

EPR362

Isotype

IgG

Carrier free

Yes

Reacts with

Human

Applications

IP, IHC-P, ICC/IF, WB, Flow Cyt (Intra)

applications

Immunogen

The exact immunogen used to generate this antibody is proprietary information.

Specificity

Expression levels of the target protein vary between different tissue/cell lines and in some cases induction may be required before a signal is observed.

Reactivity data

{ "title": "Reactivity Data", "filters": { "stats": ["", "Species", "Dilution Info", "Notes"], "tabs": { "all-applications": {"fullname" : "All Applications", "shortname": "All Applications"}, "IHCP" : {"fullname" : "Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections)", "shortname":"IHC-P"}, "IP" : {"fullname" : "Immunoprecipitation", "shortname":"IP"}, "WB" : {"fullname" : "Western blot", "shortname":"WB"}, "ICCIF" : {"fullname" : "Immunocytochemistry/ Immunofluorescence", "shortname":"ICC/IF"}, "FlowCytIntra" : {"fullname" : "Flow Cytometry (Intracellular)", "shortname":"Flow Cyt (Intra)"} }, "product-promise": { "all": "all", "testedAndGuaranteed": "tested", "guaranteed": "expected", "predicted": "predicted", "notRecommended": "not-recommended" } }, "values": { "Human": { "IHCP-species-checked": "testedAndGuaranteed", "IHCP-species-dilution-info": "", "IHCP-species-notes": "<p></p> Perform heat-mediated antigen retrieval before commencing with IHC staining protocol.", "IP-species-checked": "testedAndGuaranteed", "IP-species-dilution-info": "", "IP-species-notes": "<p></p>", "WB-species-checked": "testedAndGuaranteed", "WB-species-dilution-info": "", "WB-species-notes": "<p></p>", "ICCIF-species-checked": "testedAndGuaranteed", "ICCIF-species-dilution-info": "", "ICCIF-species-notes": "<p></p>", "FlowCytIntra-species-checked": "testedAndGuaranteed", "FlowCytIntra-species-dilution-info": "", "FlowCytIntra-species-notes": "<p><a href='/en-us/products/primary-antibodies/rabbit-igg-monoclonal-epr25a-isotype-control-low-endotoxin-azide-free-ab199376'>ab199376</a> - Rabbit monoclonal IgG, is suitable for use as an isotype control with this antibody.</p>" } } }

Product details

What is this antibody validated in?
Anti-p21 antibody [EPR362] - BSA and Azide free (ab218311) is a rabbit recombinant monoclonal antibody and is validated for use in Western Blot (WB), Flow Cytometry (Intra), Flow Cytometry (Flow Cyt), Immunoprecipitation (IP), Immunohistochemistry (IHC-P), Immunocytochemistry/immunofluorescence (ICC/IF) in Human samples.

What is the molecular weight of p21?
Anti-p21 [EPR362] - BSA and Azide free (ab218311) specifically detects a band for p21 (UniProt: P38936) at a molecular weight of 21kDa.

Trusted by the scientific community
Anti-p21 [EPR362] - BSA and Azide free (ab218311) was first used in a scientific publication in 2017 and has been cited over 20 times in peer-reviewed journals.

Trial sizes available!
Test your antibody or perform pre-screening before committing to a larger quantity. Sold in 10µl. Discover our selection of trial-size antibodies.

Specificity confirmed
The specificity of Anti-p21 antibody [EPR362] - BSA and Azide free (ab218311) has been confirmed by Western blot testing in CDKN1A Knockout HeLa cell line, ab255349.

Other related products
We have a range of other formats of antibody clone [EPR362] also available for your convenience: ab109520, Carrier free - ab218311, Alexa Fluor® 488 - ab282187

Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.

What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:

  • - High batch-to-batch consistency and reproducibility
  • - Improved sensitivity and specificity
  • - Long-term security of supply
  • - Animal-free batch production

For more information, read more on recombinant antibodies.

Conjugation ready
Our carrier-free antibodies are typically supplied in a PBS-only formulation, purified and free of BSA, sodium azide and glycerol. This conjugation-ready format is designed for use with fluorochromes, metal isotopes, oligonucleotides, and enzymes, which makes them ideal for antibody labelling, functional and cell-based assays, flow-based assays (e.g. mass cytometry) and Multiplex Imaging applications.

Use our conjugation kits for antibody conjugates that are ready-to-use in as little as 20 minutes with 1 minute hands-on-time and 100% antibody recovery: available for fluorescent dyes, HRP, biotin and gold.

Compatibility
This product is compatible with the Maxpar® Antibody Labeling Kit from Fluidigm, without the need for antibody preparation. Maxpar® is a trademark of Fluidigm Canada Inc.

Properties and storage information

Form
Liquid
Purification technique
Affinity purification Protein A
Storage buffer
pH: 7.2 - 7.4 Constituents: PBS
Shipped at conditions
Blue Ice
Appropriate short-term storage conditions
+4°C
Appropriate long-term storage conditions
+4°C
Storage information
Do Not Freeze

Supplementary information

This supplementary information is collated from multiple sources and compiled automatically.

The p21 protein also known as CDKN1A is an important regulator of cell cycle progression. It acts as a cyclin-dependent kinase inhibitor where it binds to and inhibits the activity of cyclin-CDK2 or -CDK4 complexes. The molecular weight of p21 is approximately 21 kDa. Cellular expression of p21 is diverse; it occurs in various tissues reflecting its broad role in maintaining cell cycle control. This protein's expression level is often assessed using techniques such as p21 western blotting p21 ELISA and p21 IHC staining.
Biological function summary

P21 plays a critical role in cell cycle regulation and DNA damage response. It associates with the p53 tumor suppressor protein forming an essential part of the p53 signaling pathway under stress conditions. p21 arrests cells in G1 phase allowing DNA repair or leading to cellular senescence. Through these mechanisms p21 integrates signals from stress and damage emphasizing its importance as a mediator in cellular checkpoint control.

Pathways

P21 is closely involved in the p53 and the Transforming Growth Factor-beta (TGF-Β) signaling pathways. This integration helps in transmitting growth-inhibitory signals. p21 interacts with proteins such as p53 and cyclins ensuring precise regulation of the cell cycle and growth arrest when necessary. Triggered by p53 activation p21 contributes to preventing undisturbed cell proliferation acting as a safeguard against tumor formation.

P21's deregulation associates with cancer and age-related diseases. Its impairment is a common feature in many cancers often linked with defects in the p53 pathway. Reduced p21 expression can contribute to unchecked cell division and tumor progression. Moreover in age-related diseases p21's role in promoting cellular senescence connects it with degenerative conditions. The intricate relationship between p21 and proteins such as p53 and cyclins highlights its potential as a therapeutic target for these disorders.

Product protocols

For this product, it's our understanding that no specific protocols are required. You can visit:

Target data

Plays an important role in controlling cell cycle progression and DNA damage-induced G2 arrest (PubMed : 9106657). Involved in p53/TP53 mediated inhibition of cellular proliferation in response to DNA damage. Also involved in p53-independent DNA damage-induced G2 arrest mediated by CREB3L1 in astrocytes and osteoblasts (By similarity). Binds to and inhibits cyclin-dependent kinase activity, preventing phosphorylation of critical cyclin-dependent kinase substrates and blocking cell cycle progression. Functions in the nuclear localization and assembly of cyclin D-CDK4 complex and promotes its kinase activity towards RB1. At higher stoichiometric ratios, inhibits the kinase activity of the cyclin D-CDK4 complex. Inhibits DNA synthesis by DNA polymerase delta by competing with POLD3 for PCNA binding (PubMed : 11595739). Negatively regulates the CDK4- and CDK6-driven phosphorylation of RB1 in keratinocytes, thereby resulting in the release of E2F1 and subsequent transcription of E2F1-driven G1/S phase promoting genes (By similarity).
See full target information CDKN1A

Publications (34)

Recent publications for all applications. Explore the full list and refine your search

Bioactive materials 42:52-67 PubMed39280584

2024

Vascular wall microenvironment: Endothelial cells original exosomes mediated melatonin-suppressed vascular calcification and vascular ageing in a m6A methylation dependent manner.

Applications

Unspecified application

Species

Unspecified reactive species

Su-Kang Shan,Xiao Lin,Feng Wu,Chang-Chun Li,Bei Guo,Fu-Xing-Zi Li,Ming-Hui Zheng,Yi Wang,Qiu-Shuang Xu,Li-Min Lei,Ke-Xin Tang,Yun-Yun Wu,Jia-Yue Duan,Ye-Chi Cao,Yan-Lin Wu,Chang-Ming Tan,Zi-Han Liu,Zhi-Ang Zhou,Xiao-Bo Liao,Feng Xu,Ling-Qing Yuan

Journal of nanobiotechnology 22:292 PubMed38802882

2024

Effective delivery of miR-150-5p with nucleus pulposus cell-specific nanoparticles attenuates intervertebral disc degeneration.

Applications

Unspecified application

Species

Unspecified reactive species

Hua Jiang,Hongyu Qin,Qinghua Yang,Longao Huang,Xiao Liang,Congyang Wang,Abu Moro,Sheng Xu,Qingjun Wei

Acta neuropathologica 147:78 PubMed38695952

2024

Characterisation of premature cell senescence in Alzheimer's disease using single nuclear transcriptomics.

Applications

Unspecified application

Species

Unspecified reactive species

Nurun N Fancy,Amy M Smith,Alessia Caramello,Stergios Tsartsalis,Karen Davey,Robert C J Muirhead,Aisling McGarry,Marion H Jenkyns,Eleonore Schneegans,Vicky Chau,Michael Thomas,Sam Boulger,To Ka Dorcas Cheung,Emily Adair,Marianna Papageorgopoulou,Nanet Willumsen,Combiz Khozoie,Diego Gomez-Nicola,Johanna S Jackson,Paul M Matthews

Nature 626:574-582 PubMed38086421

2023

A molecular switch for neuroprotective astrocyte reactivity.

Applications

Unspecified application

Species

Unspecified reactive species

Evan G Cameron,Michael Nahmou,Anna B Toth,Lyong Heo,Bogdan Tanasa,Roopa Dalal,Wenjun Yan,Pratima Nallagatla,Xin Xia,Sarah Hay,Cara Knasel,Travis L Stiles,Christopher Douglas,Melissa Atkins,Catalina Sun,Masoumeh Ashouri,Minjuan Bian,Kun-Che Chang,Kristina Russano,Sahil Shah,Mollie B Woodworth,Joana Galvao,Ramesh V Nair,Michael S Kapiloff,Jeffrey L Goldberg

Journal of neurochemistry 166:517-533 PubMed37278117

2023

Characterizing microglial senescence: Tau as a key player.

Applications

Unspecified application

Species

Unspecified reactive species

Deniz Karabag,Hannah Scheiblich,Angelika Griep,Francesco Santarelli,Stephanie Schwartz,Michael T Heneka,Christina Ising

Life science alliance 6: PubMed37197981

2023

Connexin 37 sequestering of activated-ERK in the cytoplasm promotes p27-mediated endothelial cell cycle arrest.

Applications

Unspecified application

Species

Unspecified reactive species

Bipul R Acharya,Jennifer S Fang,Erin D Jeffery,Nicholas W Chavkin,Gael Genet,Hema Vasavada,Elizabeth A Nelson,Gloria M Sheynkman,Martin J Humphries,Karen K Hirschi

International journal of oncology 59: PubMed34476495

2021

MicroRNA‑93 knockdown inhibits acute myeloid leukemia cell growth via inactivating the PI3K/AKT pathway by upregulating DAB2.

Applications

Unspecified application

Species

Unspecified reactive species

Jiwei Huang,Ruozhi Xiao,Xiaozhen Wang,Bijay Khadka,Zhigang Fang,Mingxue Yu,Ling Zhang,Jieying Wu,Jiajun Liu

Molecular therapy oncolytics 22:326-335 PubMed34553022

2021

Elevated Stratifin promotes cisplatin-based chemotherapy failure and poor prognosis in non-small cell lung cancer.

Applications

Unspecified application

Species

Unspecified reactive species

Yu-Shui Ma,Li-Kun Hou,Shi-Hua Yao,Ji-Bin Liu,Xue-Chen Yu,Yi Shi,Xiao-Li Yang,Wei Wu,Chun-Yan Wu,Geng-Xi Jiang,Da Fu

Open medicine (Warsaw, Poland) 16:931-943 PubMed34222668

2021

lncRNA MALAT1 regulated ATAD2 to facilitate retinoblastoma progression via miR-655-3p.

Applications

Unspecified application

Species

Unspecified reactive species

Yuxin Zhao,Zhaoxia Wang,Meili Gao,Xuehong Wang,Hui Feng,Yuanyuan Cui,Xia Tian

FASEB journal : official publication of the Federation of American Societies for Experimental Biology 35:e21410 PubMed33617078

2021

Enhancing the potential of aged human articular chondrocytes for high-quality cartilage regeneration.

Applications

Unspecified application

Species

Unspecified reactive species

He Shen,Yuchen He,Ning Wang,Madalyn R Fritch,Xinyu Li,Hang Lin,Rocky S Tuan
View all publications

Product promise

We are committed to supporting your work with high-quality reagents, and we're here for you every step of the way. In the unlikely event that one of our products does not perform as expected, you're protected by our Product Promise.
For full details, please see our Terms & Conditions

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com